P, C., JN, C., F, E., E, H., J, X., D, I., . . . RB, L. (2026). The myeloid cell leukaemia-1 inhibitor MIK665 is a potent therapy in preclinical models of paediatric acute myeloid leukaemia. British journal of haematology. https://doi.org/10.1111/bjh.70596
Chicago Style (17th ed.) CitationP, Connerty, et al. "The Myeloid Cell Leukaemia-1 Inhibitor MIK665 Is a Potent Therapy in Preclinical Models of Paediatric Acute Myeloid Leukaemia." British Journal of Haematology 2026. https://doi.org/10.1111/bjh.70596.
MLA (9th ed.) CitationP, Connerty, et al. "The Myeloid Cell Leukaemia-1 Inhibitor MIK665 Is a Potent Therapy in Preclinical Models of Paediatric Acute Myeloid Leukaemia." British Journal of Haematology, 2026, https://doi.org/10.1111/bjh.70596.
Warning: These citations may not always be 100% accurate.
